Israeli pharmaceutical giant Teva has announced that the American Food and Drugs Administration (FDA) has granted approval for Synribo, an injectable drug for treating leukemia. The company says that the drug will soon be available for prescription.
Related posts
Clean Energy Company That Mimics The Sun Raises $22M
February 02, 2023
Blood Test Offers Hope For Lung Cancer Patients
February 02, 2023
Israel Opens Its First Satellite Observatory
February 02, 2023
Cloud Data-Securing Startup Raises $30M
February 01, 2023
Facebook comments